Test Post
Test
Groundbreaking Treatment for Metastatic Uveal Melanoma Approved for use in the UK Ocular Melanoma UK (OMUK), formerly known as OcuMel UK, celebrates the landmark announcement that Tebentafusp, a pioneering treatment for metastatic uveal melanoma, is now available to patients in the UK. This approval represents a historic breakthrough, offering renewed hope to people living with
Tebentafusp update Read More »